Surfactant alterations in horses with recurrent airway obstruction at various clinical stages
- PMID: 20367056
- DOI: 10.2460/ajvr.71.4.468
Surfactant alterations in horses with recurrent airway obstruction at various clinical stages
Abstract
Objective: To evaluate the phospholipid composition and function of surfactant in horses with recurrent airway obstruction (RAO) at various clinical stages and compare these properties with findings in horses without RAO.
Animals: 7 horses with confirmed RAO and 7 without RAO (non-RAO horses).
Procedures: Pairs of RAO-affected and non-RAO horses were evaluated before, during, and after exposure to hay. Evaluations included clinical scoring, lung function testing, airway endoscopy, and bronchoalveolar lavage fluid (BALF) absolute and differential cell counts. Cell-free BALF was separated into crude surfactant pellet and supernatant by ultracentrifugation, and phospholipid and protein concentrations were determined. Phospholipid composition of crude surfactant pellets and surface tension were evaluated with high-performance liquid chromatography and a pulsating bubble surfactometer, respectively. Findings were compared statistically via mixed-effects, repeated-measures ANOVA.
Results: Total phospholipid concentration in BALF was lower in RAO-affected versus non-RAO horses at all sample collection times. In the RAO-affected group, total phospholipid concentration was lower during exposure to hay than before or after exposure. There were no significant differences in BALF protein concentration, percentages of phospholipid classes, or surface tension between or within groups of horses.
Conclusions and clinical relevance: All clinical stages of RAO-affected horses were characterized by low surfactant concentration in BALF. Exacerbation of RAO led to an additional decrease in surfactant concentration. Causes for low surfactant concentration in RAO-affected horses remain to be determined. Low phospholipid concentration may render RAO-affected horses more susceptible than unaffected horses to surfactant alterations and contribute to clinical disease status and progression.
Similar articles
-
Abnormalities in lung surfactant in horses clinically affected with recurrent airway obstruction (RAO).J Vet Intern Med. 2008 Nov-Dec;22(6):1452-5. doi: 10.1111/j.1939-1676.2008.0177.x. Epub 2008 Aug 25. J Vet Intern Med. 2008. PMID: 18761600
-
DNA binding activity of transcription factors in bronchial cells of horses with recurrent airway obstruction.Vet Immunol Immunopathol. 2006 Sep 15;113(1-2):11-20. doi: 10.1016/j.vetimm.2006.03.020. Epub 2006 Jun 5. Vet Immunol Immunopathol. 2006. PMID: 16753225
-
IgE-bearing cells in bronchoalveolar lavage fluid and allergen-specific IgE levels in sera from RAO-affected horses.J Vet Med A Physiol Pathol Clin Med. 2007 Feb;54(1):40-7. doi: 10.1111/j.1439-0442.2007.00870.x. J Vet Med A Physiol Pathol Clin Med. 2007. PMID: 17359454
-
The role of oxidative stress in an equine model of human asthma.Redox Rep. 2006;11(2):46-52. doi: 10.1179/135100006X101057. Redox Rep. 2006. PMID: 16686994 Review.
-
Surfactant in airway disease.Chest. 2008 Apr;133(4):975-80. doi: 10.1378/chest.07-2404. Chest. 2008. PMID: 18398117 Review.
Cited by
-
The Contribution of Oxidative Stress and Inflamm-Aging in Human and Equine Asthma.Int J Mol Sci. 2017 Dec 5;18(12):2612. doi: 10.3390/ijms18122612. Int J Mol Sci. 2017. PMID: 29206130 Free PMC article. Review.
-
Dynamics of DHA and EPA supplementation: incorporation into equine plasma, synovial fluid, and surfactant glycerophosphocholines.Metabolomics. 2021 Apr 17;17(5):41. doi: 10.1007/s11306-021-01792-5. Metabolomics. 2021. PMID: 33866431
-
Fatty acid fingerprints in bronchoalveolar lavage fluid and its extracellular vesicles reflect equine asthma severity.Sci Rep. 2023 Jun 17;13(1):9821. doi: 10.1038/s41598-023-36697-x. Sci Rep. 2023. PMID: 37330591 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources